Clinical

Doctor Heather M. Gilmartin talks about ways the infection prevention profession can lure more young health care professionals into its ranks.

In this Deep Dive, Omar Reda, MD, discusses how clinicians of all kinds can recognize and treat trauma.

Doctors Butler and Gerhart discuss the reduction in rates of seasonal influenza during the COVID-19 pandemic. They also discuss how the enhanced infection prevention measures may have played a role in the decline.

Dr. Jeffery Auletta discusses recently published research regarding mismatched unrelated donors stem cell transplant in patients with acute leukemias and myelodysplastic syndrome. The findings indicates that HLA-matched unrelated donors may offer better outcomes for patient’s vs half-matched related donors.

David Hyun joins After Hours to discuss the issue of antibiotic resistance and minimizing inappropriate prescribing of antibiotics so as to slow the spread of “superbugs".

A panel of experts discusses the benefits and downsides in choice of diabetes treatments discussed at ADA 2021.

Dr. Rupa Wong, Rupa Wong, MD, an ophthalmologist practicing at Honolulu Eye Clinic, weighs in on myopia in children, discusses how the pandemic impacted eye health in children, and best practices to maintain optimal eye health as children get ready for the new school year.

Michael Samsonov discusses the repositioning of existing drugs for newly emerged viral infections with a focus on olokizumab. We delve into the importance of repositioning existing drugs during the COVID-19 pandemic, the real-world evidence tools his team is utilizing, and future research he is planning on doing in the future to address this opportunity.

Pharmacy Times interviewed Jay Lieberman, MD, a pediatric infectious disease specialist and senior medical director of PRA Health Sciences to discuss the future of COVID-19 disease and vaccines for adolescents and children, specifically in light of his perspective on the enrollment of his twin daughters in the Moderna COVID-19 vaccine trial.

There are a number of clinical trials going on to test treatments for chronic cough, but they have a big challenge: these trials all have a large placebo effect. This large placebo effect puts trials at risk of being unblinded, making it difficult to actually understand the pharmacological efficacy of the treatments being studied.

James M. Shwayder, MD, JD delves into his Legally Speaking column from the May issue of Contemporary OB/GYN®, which analyzed a case in which methotrexate was used in an intrauterine pregnancy that eventually led to fetal demise.

Dr. Emad Rizk, CEO and president of analytics company Cotiviti discusses value-based care success, how close provider-payer partnerships can help deliver the right care, and technology available to help make the most of value care models.

Dr. Marc Rosenberg elightens viewers on loosening COVID-19 protocols in veterinary clinics.

Andy Pawson discusses new contact lenses his company, Alcon, created.

Dr. Jessica Ailani and Dr. Rashmi Halker-Singh discuss a number of challenges physicians face in their day-to-day professional lives, including the situation in which patient decides that they want to switch their treating doctor, how to deal with getting a negative review from a patient, and the importance of having a support community in your professional life.

The 2021 ASCO Annual Meeting was held in June, and all eyes in the oncology community were watching. So, what were some of the most exciting data to come out of the event? Here, some experts in the field share their insights.

In this edition of Deep Dive, Jonathan E. Alpert, MD, PhD discusses mood disorders and the surprising symptoms that male patients may present.

In this video, urologists and long-time friends Steven Wahle, MD, and Henry Rosevear, MD, compare their experiences of the health care system from the patient point of view, discuss different urology practice types, and give their thoughts on recent coding changes.

Oncologists’ understanding of a patient’s pain, as well as how to respond to it, have changed over time with new research and technology. This week, CURE is sharing the best methods health care providers use to understand and manage their patients’ pain levels. They explore various topics, from the concern of the opioid epidemic to medical marijuana.

As disparities in health care coverage and access have become spotlighted amid the COVID-19 pandemic, health economics and outcomes research (HEOR) may play a significant role in addressing gaps present in disadvantaged communities and the health care system. Dr. Amy Abernethy speaks on recent innovations within HEOR, how the FDA used data in their response to the pandemic, and the current state of the agency amid an ongoing search for a new FDA Commissioner.

In this segment, you will hear from Dr. Elaine Apperson as she discusses how she attempts to ease the burden pediatric diabetes can have on caregivers and patients themselves.

Chronic cough is any cough that lasts more than 8 weeks. For some patients there is an underlying cause that can be treated, but for others, it does not resolve with treatment. These patients can spend months, sometimes years, visiting multiple doctors and specialists before they are diagnosed with a refractory chronic cough and provided the tools to help manage their cough.

Gale Simons-Poole updates us on the Paycheck Protection Program and what small business owners—including dentists and clinicians—need to know about loan forgiveness. Topics include the basics of PPP loan forgiveness, what borrowers need to qualify, common misconceptions about PPP forgiveness, and some of the most common mistakes that borrowers make when applying for PPP loan forgiveness.

Laura E. Riley, MD. Riley is chair of Obstetrics and Gynecology at Weill Cornell Medicine and Obstetrician and Gynecologist-in-Chief at New York-Presbyterian Hospital in New York City. She specializes in obstetric infectious disease and is a member of the American College of Obstetricians and Gynecologists (ACOG) COVID-19 Task Force.

Upon its publication in the New England Journal of Medicine, the phase 3 CheckMate-9ER trial garnered significant attention across social media. Study authors Toni K. Choueiri, MD, and Robert J. Motzer, MD, discussed the significance of the trial and shed light on ongoing research in advanced RCC.

Doron Schneider, VP, Population Health Services at Tandigm Health, joins to discuss how value-based care strategies helped some independent practices survive during the COVID-19 pandemic.

Dr. Brandon Repko talks about how the WavelinQ EndoAVF system gives physicians a minimally invasive option for creating an AV fistula for patients who need hemodialysis to survive. Repko is part of a postmarket study called CONNECT-AV following patients treated with the device for an additional 24 months.

Pharmacy Times interviewed Michael Holden, FRPharmS, FRSPH, associate director of Pharmacy Complete in the United Kingdom, to discuss some of the key differences between the role of the pharmacist in the United Kingdom versus the United States.

In light of the FDA meeting about the COVID vaccine in children younger than 12 years, which included discussions on safety, lack of severe cases in the age group, do you agree or disagree with the FDA’s concerns and why?

Laura Bukavina, MD, MPH, and Justin Dubin, MD, discuss how findings of a recent peer-reviewed study point to a rise in academic urology programs’ engagement on Twitter for marketing purposes. They also discuss their own usage of social media and share advice for medical professionals using social media.